Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui-Jin Ji

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cell Insight|May 16, 2023
Current advances of CRISPR-Cas technology in cell therapyHou-Yuan Qiu, Rui-Jin Ji, Ying Zhang
Cell Insight|February 5, 2025
Precision epitope editing: A path to advanced immunotherapiesRui-Jin Ji, Mu-Yao Wang, Ying Zhang
Nature Chemical Biology|April 2, 2025
TOPO-seq reveals DNA topology-induced off-target activity by Cas9 and base editorsMin Duan, Pan Gao, Yi-Zhou Zhang, et al.
Cell Stem Cell|October 1, 2024
Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemiaRui-Jin Ji, Guo-Hua Cao, Wei-Qiang Zhao, et al.
Cell Stem Cell|November 21, 2023
Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCsWenyan Han, Hou-Yuan Qiu, Shangwu Sun, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cell Insight|May 16, 2023
Current advances of CRISPR-Cas technology in cell therapyHou-Yuan Qiu, Rui-Jin Ji, Ying Zhang
Cell Insight|February 5, 2025
Precision epitope editing: A path to advanced immunotherapiesRui-Jin Ji, Mu-Yao Wang, Ying Zhang
Nature Chemical Biology|April 2, 2025
TOPO-seq reveals DNA topology-induced off-target activity by Cas9 and base editorsMin Duan, Pan Gao, Yi-Zhou Zhang, et al.
Cell Stem Cell|October 1, 2024
Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemiaRui-Jin Ji, Guo-Hua Cao, Wei-Qiang Zhao, et al.
Cell Stem Cell|November 21, 2023
Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCsWenyan Han, Hou-Yuan Qiu, Shangwu Sun, et al.
Pageof 1